QT
SNDX icon

Quantbot Technologies’s Syndax Pharmaceuticals SNDX Stock Holding History

Quantbot Technologies’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,350
Closed -$54.9K – 2226
2026
Q1 		$54.9K Buy
2,350
+1,161
+98% +$25.2K ﹤0.01% 1406
2025
Q4 		$25K Sell
1,189
-2,282
-66% -$39.8K ﹤0.01% 1555
2025
Q3 		$53.4K Buy
+3,471
New +$45.4K ﹤0.01% 1515
2025
Q1 		– Sell
-1,086
Closed -$14.4K – 1846
2024
Q4 		$14.4K Sell
1,086
-1,456
-57% -$24.9K ﹤0.01% 1368
2024
Q3 		$48.9K Buy
+2,542
New +$52.5K ﹤0.01% 1292
2023
Q4 		– Sell
-9,000
Closed -$131K – 1959
2023
Q3 		$131K Buy
+9,000
New +$170K 0.01% 1028
2022
Q2 		– Sell
-4,900
Closed -$85K – 2100
2022
Q1 		$85K Sell
4,900
-446
-8% -$7.51K 0.01% 1082
2021
Q4 		$117K Buy
+5,346
New +$98.8K 0.01% 838
2021
Q2 		– Sell
-700
Closed -$15K – 1836
2021
Q1 		$15K Hold
700
– – ﹤0.01% 1209
2020
Q4 		$15K Sell
700
-200
-22% -$4.15K ﹤0.01% 1054
2020
Q3 		$13K Buy
+900
New +$13.7K ﹤0.01% 1070

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Quantbot Technologies's SNDX Position: Q2 2026 in Review

Quantbot Technologies sold out of Syndax Pharmaceuticals (SNDX) in Q2 2026, closing a stake of 2,350 shares — an estimated $54.9K sold.

Quantbot Technologies first reported a position in SNDX in Q3 2020 and held it in 11 quarters. The position peaked at $131K in Q3 2023. 243 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Quantbot Technologies reported no remaining Syndax Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Quantbot Technologies sold 2,350 Syndax Pharmaceuticals shares in Q2 2026, an estimated $54.9K.
  • Quantbot Technologies first reported a position in Syndax Pharmaceuticals in Q3 2020 and held it in 11 quarters.
  • Quantbot Technologies's Syndax Pharmaceuticals position peaked at $131K in Q3 2023.
  • 243 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.